World-First Discovery of FLASH Effect Conditions Using Compact Carbon Ion Synchrotron Opens Door to Safer Cancer Therapy
en-GBde-DEes-ESfr-FR

World-First Discovery of FLASH Effect Conditions Using Compact Carbon Ion Synchrotron Opens Door to Safer Cancer Therapy


New findings reveal how ultra-high dose rate irradiation can protect normal cells, paving the way for next-generation radiotherapy

Osaka, Japan―A research team from The University of Osaka has made a significant breakthrough in cancer radiotherapy by identifying conditions under which carbon ion beams—delivered at ultra-high dose rates (uHDR)—can protect normal cells. This phenomenon, known as the “FLASH effect,” could revolutionize cancer treatment by reducing side effects and improving patients’ quality of life.

Radiation therapy is a standard cancer treatment, but it often damages not only tumors but also surrounding healthy tissues. The FLASH effect, discovered in 2014, shows that delivering radiation at dose rates exceeding 40 Gy/s can spare normal tissue while maintaining tumor control. Although FLASH effects have been reported with X-rays, electron and proton beams, evidence for similar effects using carbon ion beams—known for their high precision and strong biological impact—was lacking. Due to the complexity of creating a controlled uHDR environment for carbon ions, little was known about the specific conditions needed for this effect to occur.

Using a specially modified synchrotron-based system at the Osaka Heavy Ion Therapy Center, the researchers irradiated three types of human cells, two normal and one tumor, under varying conditions of oxygen concentration and linear energy transfer (LET). They found that even under normoxic (normal oxygen) conditions, uHDR carbon ion beams produced a significant “cell-sparing” effect—an increase in the survival of normal cells compared to conventional dose rates.

This sparing effect was more prominent when using higher LET (50 keV/μm), a value typical near tumor sites in carbon therapy. Moreover, markers of DNA damage were notably lower in cells exposed to FLASH-like irradiation, suggesting a fundamental biological mechanism distinct from conventional radiation damage.

“This is the first time we have observed the cell-sparing effect with carbon ions under normoxic conditions,” said Kazumasa Minami, the lead author, “it was a challenging experiment, but the results open new possibilities for safer radiotherapy.” says corresponding author, Masashi Yagi.

This is the first study to demonstrate the FLASH effect under normal oxygen conditions using carbon ions, opening new possibilities for applying this technique in clinical settings. By fine-tuning irradiation parameters, such as dose, LET, and oxygen levels, researchers hope to deliver powerful cancer treatments with fewer side effects. The team envisions future studies expanding into immune response effects and tumor-specific applications.
###
The article, “The Appropriate Conditions for the Cell Sparing (FLASH) Effect Exist in Ultra‐high Dose Rate Carbon Ion Irradiation,” was published in Anticancer Research at DOI: https://doi.org/10.21873/anticanres.17483
Title: The Appropriate Conditions for the Cell Sparing (FLASH) Effect Exist in Ultra‐high Dose Rate Carbon Ion Irradiation
Journal: Anticancer Research
Authors: Kazumasa Minami, Masashi Yagi, Kazuki Fujita, Kana Nagata, Ryo Hidani, Noriaki Hamatani, Toshiro Tsubouchi, Masaaki Takashima, Masumi Umezawa, Takuya Nomura, Masaki Shimizu, Yoshiaki Kuwana, Jiro Fujimoto, Shinichi Shimizu and Kazuhiko Ogawa
DOI: 10.21873/anticanres.17483
Funded by:
Japan Society for the Promotion of Science
Joint research agreement among Osaka University
Hitachi High‐Tech Corporation
Osaka Heavy Ion Therapy Center
Osaka Heavy Ion Administration Company
Hyogo Medical University
Fichiers joints
  • Fig. 1 Comparison of cell surviving fraction. For the same irradiation conditions (cells, LET, oxygen concentration, and dose), the number of surviving cells is higher (sparing effect) for the ultra-high dose rate (uHDR, red) than for the normal dose rate (NDR, blue). The difference in the number of colonies is also evident in the petri dish photograph (right). , Original content, No restrictions, Masashi Yagi
Regions: Asia, Japan
Keywords: Health, Medical, Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement